KPV 10mg

KPV 10mg is a synthetic tripeptide composed of Lysine-Proline-Valine (KPV). It is derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH) and is supplied as a compact research reference compound.

The primary research context for KPV involves intracellular signalling and cytokine biology. Its short sequence and relationship to α-MSH make it useful in experimental studies where investigators are examining peptide signalling, receptor-associated pathways or cellular responses.

KPV should be evaluated according to the experimental system rather than treated as having one universal biological effect. Research outcomes can depend on cell type, assay design, concentration, exposure period and other experimental variables.

The 10mg presentation provides a defined quantity for laboratory procurement. Researchers should use the current product page and batch COA for the latest product-specific analytical information. Each batch is supplied with a Certificate of Analysis (COA) from independent third-party testing, covering HPLC purity and mass-spectrometry identity.

For research records, document the exact product, batch, preparation conditions and assay parameters. Follow the laboratory's established procedures for storage, handling and disposal.

KPV 10mg is for laboratory research use only. It is not a medicinal product, is not licensed by the MHRA and is not intended for human or veterinary use, diagnosis, treatment or self-administration. Sold only to qualified researchers aged 18 or over.